Related Experiment Video
Updated: Aug 14, 2026

A 3D Organotypic Melanoma Spheroid Skin Model
Published on: May 18, 2018
Autophagy in Melanoma: Molecular Mechanisms and Therapeutic Perspectives
Dominika Stencel1, Dorota Wrześniok1
1Department of Pharmaceutical Chemistry, Faculty of Pharmaceutical Sciences in Sosnowiec, Medical University of Silesia in Katowice, 4 Jagiellońska Str., 41-200 Sosnowiec, Poland.
Abstract:
Melanoma is a malignant tumor that originates in pigment-producing cells called melanocytes. This type of cancer remains a major public health challenge due to its high metastatic potential and resistance to treatment. Autophagy is a catabolic process that enables the controlled degradation of damaged cellular organelles and unnecessary or abnormal macromolecules. Its primary function is to maintain intracellular homeostasis and cell survival. There are three main types of autophagy: macroautophagy, microautophagy and chaperone-mediated autophagy (CMA). The role of autophagy in oncogenesis is multifaceted and context-dependent-depending on the type of cancer and its stage of development. Autophagy can either promote tumor progression or act as a tumor-suppressive mechanism. Factors influencing the role of autophagy in cancer include inflammation, crosstalk with apoptosis and resistance to anticancer therapies. Current research is focused on the use of both autophagy inhibitors and autophagy inducers as potential strategies to improve the effectiveness of melanoma treatment.
Insights
Melanoma, a dangerous skin cancer, involves autophagy, a cellular process. Research explores using autophagy modulators to enhance melanoma treatment effectiveness.
Area of Science:
- Oncology
- Cell Biology
- Biochemistry
Background:
- Melanoma is a significant public health concern due to its high metastatic potential and treatment resistance.
- Autophagy is a cellular degradation process crucial for maintaining homeostasis and cell survival.
- Autophagy exists in three main forms: macroautophagy, microautophagy, and chaperone-mediated autophagy (CMA).
Purpose of the Study:
- To explore the multifaceted role of autophagy in melanoma development and progression.
- To investigate how autophagy influences cancer characteristics such as inflammation, apoptosis crosstalk, and therapeutic resistance.
- To evaluate the potential of modulating autophagy as a therapeutic strategy for melanoma.
Main Methods:
- Literature review of current research on autophagy and melanoma.
- Analysis of studies investigating the dual role of autophagy (tumor-promoting vs. tumor-suppressive) in different cancer contexts.
- Examination of preclinical and clinical data on autophagy inhibitors and inducers in melanoma models.
Main Results:
- Autophagy's role in oncogenesis is complex and context-dependent, varying with cancer type and stage.
- Autophagy can act as either a tumor promoter or a tumor suppressor in melanoma.
- Factors like inflammation and crosstalk with apoptosis significantly influence autophagy's function in cancer.
Conclusions:
- Targeting autophagy presents a promising avenue for improving melanoma treatment efficacy.
- Both autophagy inhibitors and inducers are being explored as potential therapeutic agents.
- Further research is needed to fully elucidate and harness the therapeutic potential of autophagy modulation in melanoma.
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Autophagy
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
The Intrinsic Apoptotic Pathway
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Delivery Pathways to the Lysosome
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...

